ELEGEN

📍 San Carlos, United States🗓 Founded 2017👥 60 employees💰 Last funded 2020
Biotechnology🌐 elegenbio.com
Website LinkedIn
We are now at the dawn of the synthetic biology revolution, which will spawn new applications, markets, and business models, improving human lives in countless ways. This revolution will be driven by new technologies that enable DNA writing at speed and scale. To catalyze this revolution, Elegen is creating a suite of ground-breaking technologies to achieve DNA writing with unparalleled speed, cost, and quality. Elegen is unlocking the power to reprogram biology and create biologic solutions in order to solve some of humanity’s greatest challenges. Founded and led by Dr. Matthew Hill and located in San Carlos, CA, Elegen is a stealth-mode company that is well capitalized by top life science investors, including Andreessen Horowitz, 8VC, and KdT. The company is advised and staffed by leading biotechnology scientists and entrepreneurs, including Dr. Marc Unger, inventor of the Nanoflex™ valve and former CSO of Fluidigm. Dr. Hill has a PhD from Stanford and a proven track record of advancing innovative technologies from invention to commercial success.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in ELEGEN?
ELEGEN has 1 investors on record on gritt.io, 1 mid-stage.
When did ELEGEN last raise funding?
The most recent investment in ELEGEN recorded on gritt.io was in 2020.
When was ELEGEN founded?
ELEGEN was founded in 2017.
What industry is ELEGEN in?
ELEGEN operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is ELEGEN based?
ELEGEN is headquartered in San Carlos, United States.